State Street Corp increased its stake in shares of Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) by 6.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 794,050 shares of the medical equipment provider’s stock after buying an additional 44,699 shares during the period. State Street Corp owned about 1.99% of Zeltiq Aesthetics worth $34,560,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in the company. Bank of Montreal Can increased its position in shares of Zeltiq Aesthetics by 49.2% in the third quarter. Bank of Montreal Can now owns 4,794 shares of the medical equipment provider’s stock valued at $188,000 after buying an additional 1,580 shares during the period. Suntrust Banks Inc. bought a new position in shares of Zeltiq Aesthetics during the third quarter valued at about $201,000. First Mercantile Trust Co. bought a new position in shares of Zeltiq Aesthetics during the third quarter valued at about $204,000. PNC Financial Services Group Inc. increased its position in shares of Zeltiq Aesthetics by 2.1% in the third quarter. PNC Financial Services Group Inc. now owns 5,218 shares of the medical equipment provider’s stock valued at $205,000 after buying an additional 107 shares during the period. Finally, Commerzbank Aktiengesellschaft FI bought a new position in shares of Zeltiq Aesthetics during the fourth quarter valued at about $273,000.
Shares of Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) traded down 0.02% during mid-day trading on Friday, reaching $56.49. 342,096 shares of the company’s stock were exchanged. Zeltiq Aesthetics Inc has a one year low of $23.58 and a one year high of $56.50. The stock has a market cap of $2.28 billion, a PE ratio of 3138.33 and a beta of 1.01. The company has a 50 day moving average price of $55.89 and a 200-day moving average price of $46.23.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.com-unik.info/2017/04/21/zeltiq-aesthetics-inc-zltq-shares-bought-by-state-street-corp-updated-updated.html.
Several research analysts have recently issued reports on ZLTQ shares. Maxim Group upped their price target on shares of Zeltiq Aesthetics from $48.00 to $58.00 and gave the stock a “buy” rating in a report on Wednesday, January 4th. Zacks Investment Research upgraded shares of Zeltiq Aesthetics from a “sell” rating to a “hold” rating in a report on Wednesday, February 22nd. Canaccord Genuity reiterated a “hold” rating and set a $56.50 price target on shares of Zeltiq Aesthetics in a report on Friday, March 10th. Piper Jaffray Companies downgraded Zeltiq Aesthetics from an “overweight” rating to a “neutral” rating in a report on Monday, February 13th. Finally, Stifel Nicolaus downgraded Zeltiq Aesthetics from a “buy” rating to a “hold” rating in a report on Thursday, March 2nd. Ten research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Zeltiq Aesthetics presently has an average rating of “Hold” and a consensus price target of $49.17.
In related news, insider Mark J. Foley sold 10,000 shares of Zeltiq Aesthetics stock in a transaction that occurred on Monday, March 13th. The shares were sold at an average price of $55.77, for a total value of $557,700.00. Following the completion of the sale, the insider now directly owns 220,430 shares in the company, valued at approximately $12,293,381.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Bradley Hauser sold 3,000 shares of Zeltiq Aesthetics stock in a transaction that occurred on Tuesday, February 21st. The stock was sold at an average price of $55.64, for a total transaction of $166,920.00. Following the completion of the sale, the senior vice president now owns 49,301 shares of the company’s stock, valued at $2,743,107.64. The disclosure for this sale can be found here. 15.60% of the stock is owned by insiders.
About Zeltiq Aesthetics
ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company’s product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians.
What are top analysts saying about Zeltiq Aesthetics Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Zeltiq Aesthetics Inc and related companies.